DRMA Competitors & Alternatives
Compare Dermata Therapeutics Inc with similar stocks in the same industry
Biotechnology
DRMA
Main Stock$1.32
Tradestie Score
52
Market Cap
$3.50M
Analyst Upside
+203.0%
Top Competitors
233 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CLYM
Climb Bio, Inc. Common Stock
|
$13.24
|
$133.50M | - | 59 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$6.29
|
$114.01M | - | 60 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$27.80
|
$110.20M | - | 62 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$6.21
|
$71.69M | - | 54 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$10.68
|
$67.94M | - | 62 | Compare |
|
PALI
Palisade Bio, Inc. Common Stock
|
$1.93
|
$12.21M | 15.8 | 48 | Compare |
|
RNAZ
TransCode Therapeutics, Inc. Common Stock
|
$8.58
|
$8.85M | - | 56 | Compare |
|
ENSC
Ensysce Biosciences, Inc. Common Stock
|
$0.29
|
$7.21M | - | 52 | Compare |
|
BBLG
Bone Biologics Corp Common Stock
|
$1.26
|
$5.01M | - | 50 | Compare |
|
REVB
Revelation Biosciences, Inc. Common Stock
|
$1.04
|
$3.42M | - | 46 | Compare |
More DRMA Analysis
Data updated: Jul 14, 2026 | Industry: Biotechnology (SIC 2834)
233 stocks in this industry